We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Grifols SA (GRFS) ADR each Representing 1 Non Voting B Share

Sell:$7.61 Buy:$7.62 Change: $0.23 (2.93%)
NASDAQ:1.95%
Prices delayed by at least 15 minutes | Switch to live prices |
Sell:$7.61
Buy:$7.62
Change: $0.23 (2.93%)
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
Prices delayed by at least 15 minutes | Switch to live prices |
Sell:$7.61
Buy:$7.62
Change: $0.23 (2.93%)
Prices delayed by at least 15 minutes | Switch to live prices |
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Grifols SA is a Spain-based global specialty pharmaceutical company developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. The Company organizes its business into five divisions: Bioscience, Diagnostic, Hospital, Bio Supplies and Others. Bioscience includes manufacturing activities of plasma derivatives for therapeutic use and the sale and distribution of end products. Its diagnostic focuses on researching, developing, manufacturing and marketing in vitro diagnostics products, such as analytical instruments, reagents and software, among others, for laboratories. Hospital offers technology and services for hospitals, clinics and specialized centers for the manufacture of medicines, as well as physiological saline solution, enteral nutritional fluids and medical devices for interventional therapy. Its bio Supplies provides, mostly, biological products for non-therapeutic use.

Contact details

Address:
Parque Empresarial Can Sant Joan
Avinguda de la Generalitat, 152-158
SANT CUGAT DEL VALLES
08174
Spain
Telephone:
+34 (935) 710000
Website:
https://www.grifols.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
GRFS
ISIN:
US3984384087
Market cap:
$6.05 billion
Shares in issue:
679.63 million
Sector:
Biotechnology
Exchange:
NASDAQ
Country:
United States
Currency:
US dollar
Indices:
NASDAQ Comb. Composite

Key personnel

  • Jose Ignacio Abia
    Chief Executive Officer, Executive Director
  • Alfredo Arroyo Guerra
    Chief Financial Officer
  • Jordi Balsells Valls
    President - Plasma Procurement
  • Alberto Grifols Roura
    President - Bio Supplies
  • Antonio Martinez Martinez
    President - Diagnostic
  • Montserrat Gaja Llamas
    Chief Human Resource Officer
  • Lluis Pons Gomez
    Senior Vice President - Strategy & COO Office
  • Miguel Angel Louzan Garcia
    Chief Digital Information Officer
  • Joerg Schuettrumpf
    Chief Scientific Innovation Officer
  • Francisco Javier Guix Huguet
    Vice President - Healthcare Solutions

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.